Literature DB >> 9092851

In vivo proton magnetic resonance spectroscopy for metabolic changes in brain during chronic cerebral vasospasm in primates.

Y Handa1, M Kaneko, T Matuda, H Kobayashi, T Kubota.   

Abstract

OBJECTIVE: To study how neuronal cells are affected by development of chronic cerebral vasospasm after subarachnoid hemorrhage (SAH), the changes in neuronal metabolites during development of vasospasm were evaluated by in vivo localized proton magnetic resonance spectroscopy (MRS) in primates.
METHODS: SAH was produced by introduction of a blood clot around the right middle cerebral artery and the right side of the circle of Willis. MRS experiments were performed before SAH and on Days 7 and 14 after SAH. Multislice magnetic resonance images were obtained to locate the volume of interest (1.0 cm3) in the bilateral parietal regions. The peak areas for choline compounds, the sum of creatine and phosphocreatine, and N-acetyl-aspartate were calculated.
RESULTS: Angiograms revealed approximately 50% reduction of vessel caliber for the right main cerebral arteries on Day 7. Magnetic resonance imaging revealed no apparent cerebral infarction, even in the spasm-side hemisphere. MRS revealed a significant (P < 0.05) reduction of the N-acetyl-aspartate/creatine and phosphocreatine ratio on Days 7 and 14 and a significant increase in the choline/creatine and phosphocreatine ratio on Day 7, in the spasm-side parietal region. In the sham-operated animals, there were no significant changes in these ratios in the bilateral parietal region on Days 7 and 14 after the operation.
CONCLUSION: The results suggested that the development of cerebral vasospasm after SAH caused ischemic injury in a subpopulation of neuronal cells, even when no apparent cerebral infarction was shown. Proton MRS may be useful to evaluate how neuronal cells are affected by the ischemic insult during development of vasospasm in clinical situations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092851     DOI: 10.1097/00006123-199704000-00023

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Metabolic changes in patients with aneurysmal subarachnoid hemorrhage apart from perfusion deficits: neuronal mitochondrial injury?

Authors:  M Wagner; A Jurcoane; C Hildebrand; E Güresir; H Vatter; F E Zanella; J Berkefeld; U Pilatus; E Hattingen
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825

2.  Abnormal magnetization transfer ratios in normal-appearing white matter on conventional MR images of patients with occlusive cerebrovascular disease.

Authors:  H Kado; H Kimura; T Tsuchida; Y Yonekura; T Tokime; Y Tokuriki; H Itoh
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

3.  Postoperative changes in cerebral metabolites associated with cognitive improvement and impairment after carotid endarterectomy: a 3T proton MR spectroscopy study.

Authors:  H Saito; K Ogasawara; H Nishimoto; Y Yoshioka; T Murakami; S Fujiwara; M Sasaki; M Kobayashi; K Yoshida; Y Kubo; T Beppu; A Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

4.  Proton MR spectroscopic imaging of rhesus macaque brain in vivo at 7T.

Authors:  Oded Gonen; Songtao Liu; Gadi Goelman; Eva-Maria Ratai; Sarah Pilkenton; Margaret R Lentz; R Gilberto González
Journal:  Magn Reson Med       Date:  2008-04       Impact factor: 4.668

5.  Magnetic resonance imaging detects and predicts early brain injury after subarachnoid hemorrhage in a canine experimental model.

Authors:  Vikram Jadhav; Takashi Sugawara; John Zhang; Paul Jacobson; Andre Obenaus
Journal:  J Neurotrauma       Date:  2008-09       Impact factor: 5.269

6.  Impairments in Brain Perfusion, Metabolites, Functional Connectivity, and Cognition in Severe Asymptomatic Carotid Stenosis Patients: An Integrated MRI Study.

Authors:  Tao Wang; Feng Xiao; Guangyao Wu; Jian Fang; Zhenmeng Sun; Hongliang Feng; Junjian Zhang; Haibo Xu
Journal:  Neural Plast       Date:  2017-02-01       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.